Recent years have witnessed significant progresses in the field of diabetes treatment, with a particular focus on GLP-1 receptor agonists. Among these novel therapies, retatrutide and trizepatide are emerging as https://emilyrorr156290.dsiblogger.com/71910381/glp-1-receptor-agonists-retatrutide-and-trizepatide-advancements